Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 3/20 | 0.32 |
| ▸ | HTT | P42858 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | STK10 | O94804 | 1/20 | 0.31 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20369879 | 1.00 | MAPT (0.34) | MAPTTSHRHSD17B10KMT2AMAPK1 | |
| SCHEMBL10102396 | 0.98 | MAPT (0.33) | MAPTTSHRHSD17B10KMT2AMAPK1 | |
| SCHEMBL12424707 | 0.97 | MAPT (0.33) | MAPTTSHRHSD17B10KMT2AMAPK1 | |
| SCHEMBL10106918 | 0.97 | MAPT (0.34) | MAPTTSHRHSD17B10KMT2AMAPK1 | |
| SCHEMBL10102279 | 0.94 | MAPT (0.32) | MAPTTSHRHSD17B10KMT2AALDH1A1 | |
| SCHEMBL13868746 | 0.93 | RAB9A (0.33) | MAPTKMT2AADAM17ALDH1A1KDM4E | |
| SCHEMBL10102281 | 0.92 | MAPT (0.31) | MAPTTSHRHSD17B10KMT2AALDH1A1 | |
| SCHEMBL13868656 | 0.92 | PRKDC (0.36) | MAPTTSHRHSD17B10KMT2AMAPK1 | |
| SCHEMBL12205490 | 0.91 | KDM4E (0.32) | MAPTALDH1A1KDM4EHTTSTK10 | |
| SCHEMBL13868646 | 0.91 | PRKDC (0.36) | MAPTKMT2ASMN1; SMN2ADAM17ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240241291-A1 | FUNCTIONAL LAMINATE AND FUNCTIONAL LENS COMPRISING THE FUNCTIONAL LAMINATE | TOKUYAMA CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240241291-A1 | FUNCTIONAL LAMINATE AND FUNCTIONAL LENS COMPRISING THE FUNCTIONAL LAMINATE | TOKUYAMA CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20230272252-A1 | ADHESIVE COMPOSITION, LAMINATE AND OPTICAL ARTICLE COMPRISING THE LAMINATE | TOKUYAMA CORPORATION (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230272252-A1 | ADHESIVE COMPOSITION, LAMINATE AND OPTICAL ARTICLE COMPRISING THE LAMINATE | TOKUYAMA CORPORATION (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230260669-A1 | CURABLE COMPOSITION AND CURED BODY OF SAME | TOKUYAMA CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230260669-A1 | CURABLE COMPOSITION AND CURED BODY OF SAME | TOKUYAMA CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| EP-3345954-B1 | POLYROTAXANE, PRODUCTION METHOD THEREFOR, AND OPTICAL COMPOSITION CONTAINING SAID POLYROTAXANE | TOKUYAMA CORP (JP) | 2023-07-05 | — | — | EP | disclosed |
| EP-4183579-A1 | CURABLE COMPOSITION AND CURED BODY OF SAME | Tokuyama Corporation (JP) | 2023-05-24 | — | — | EP | disclosed |
| US-11649327-B2 | Photochromic curable composition, use thereof, and polyrotaxane monomers | TOKUYAMA CORPORATION (JP) | 2023-05-16 | — | — | US | disclosed |
| US-11649327-B2 | Photochromic curable composition, use thereof, and polyrotaxane monomers | TOKUYAMA CORPORATION (JP) | 2023-05-16 | — | — | US | disclosed |
| US-8066917-B2 | Photochromic curable composition | TOKUYAMA CORPORATION (JP) | 2011-11-29 | — | — | US | disclosed |
| US-8066917-B2 | Photochromic curable composition | TOKUYAMA CORPORATION (JP) | 2011-11-29 | — | — | US | disclosed |
| EP-2377902-A1 | COATING COMPOSITION, PROCESS FOR PRODUCTION OF THE COMPOSITION, AND LAMINATE WITH HARD COAT LAYER | Tokuyama Corporation (JP) | 2011-10-19 | — | — | EP | disclosed |
| US-20110244244-A1 | COATING COMPOSITION, PROCESS FOR PRODUCING THE COMPOSITION, AND LAMINATE HAVING A HARD COAT LAYER | TOKUYAMA CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110244244-A1 | COATING COMPOSITION, PROCESS FOR PRODUCING THE COMPOSITION, AND LAMINATE HAVING A HARD COAT LAYER | TOKUYAMA CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110062396-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
| US-20110062396-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2011-03-17 | — | — | US | disclosed |
| EP-2275418-A1 | CHROMENE COMPOUND | Tokuyama Corporation (JP) | 2011-01-19 | — | — | EP | disclosed |
| US-20100230650-A1 | PHOTOCHROMIC CURABLE COMPOSITION | GULFSTREAM INC. (CA) | 2010-09-16 | — | — | US | disclosed |
| US-20100230650-A1 | PHOTOCHROMIC CURABLE COMPOSITION | GULFSTREAM INC. (CA) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110062396-A1 | CHROMENE COMPOUND | CDYL, NR0B1, NR1H2 | MAPT 4740/4885TSHR 330/4885HSD17B10 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.